Primary anaplastic large-cell lymphoma in adults: Clinical presentation, immunophenotype, and outcome

Blood

Volumn 90, Issue 9, 1997, Pages 3727-3734

  Tilly, Hervé ^a   Gaulard, Philippe ^b   Lepage, Eric ^b   Dumontet, Charles ^b   Diebold, Jacques ^b   Plantier, Isabelle ^b   Berger, Françoise ^b   Symann, Michel ^b   Petrella, Tony ^b   Lederlin, Pierre ^b   Brière, Josette ^b  

^a CENTRE HENRI BECQUEREL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; BLEOMYCIN; CD30 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LACTATE DEHYDROGENASE; METHOTREXATE; MITOGUAZONE; MITOXANTRONE; PIRARUBICIN; PREDNISONE; TENIPOSIDE; VINCRISTINE; VINDESINE;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NULL CELL; PRIORITY JOURNAL; SURVIVAL RATE; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 0030822414     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.9.3727     Document Type: Article

References (51)

1. Stein H, Mason DY, Genies J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lemmert K: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
2. Agnarsson BA, Kadin ME: Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol 12:264, 1988
3. Delsol G, Al Saati T, Gatter K, Gerdes J, Scwaring R, Caverivière P, Rigal-Huguet F, Robert A, Stein H, Mason DY: Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas: Diagnostic value in so-called malignant histiocytosis. Am J Pathol 130:59, 1988
4. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PC, Knowles DM, Mason DY, HK Muller-Hermelink, Pileri S, Piris MA, Ralfkaier E, Warnke RA: A revised European-American, classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 84:1361, 1994
5. Kadin ME: Primary Ki-1-positive anaplastic large-cell lymphoma: A distinct clinicopathologic entity. Ann Oncol 5:25, 1994 (suppl 1)
6. Stein HD, Dallenbach F: Diffuse large cell lymphomas of B and T cell type, in Knowles DM (ed): Neoplastic Hematopathology. Baltimore, MD, Williams & Wilkias, 1992 p 675
7. Mason DY, Bastard C, Rimokh R, Dastugue N, Huret JL, Kristofferson U, Magaud JP, Nezelof C, Tilly H, Vannier JP, Hemet J, Warnke R: CD30 positive large cell lymphomas (Ki1 lymphomas) are associated with a chromosomal translocation involving 5q35. Br J Haematol 74:161, 1990
8. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT: Fusion of a kinase gene ALK, to a nucleolar protein gene, NPM, in non Hodgkin's lymphoma. Science 263:1281, 1994
9. Lamam L, Meggetto F, Al Saati T, Brugnieres L, Bressac de Paillerets B, Dastugue N, Bernheim A, Rubie H, Terrier-Laeombe MJ, Robert A, Brousset P, Rigal F, Schlaifer D, Shiota M, Mori S, Delsol G: High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood 87:284, 1996
10. Sarris AH, Luthra R, Papadimitracopoulou V, Waasdorp M, Meletios A, Dimopoulos JA, McBride JA, Cabanillas F, Duvic M, Deisseroth A, Morris SW, Pugh WC: Amplification of genomic DNA demonstrates the presence of the t(2;5)(p23;q35) in anaplastic large cell lymphoma, but not other non-Hodgkin's lymphomas, Hodgkin' s disease, or lymphomatoid papulosis. Blood 88:1771, 1996
11. + cutaneous lymphoma. Curr Probl Dermatol 19:132, 1990
12. Filippa DA, Ladanyi M, Wollner N, Straus DJ, O'Brien JP, Portlock C, Gangi M, Sun M: CD30 (Ki-1)-positive malignant lymphomas: Clinical, immunophenotypic, histologic, and genetic characteristics and differences with Hodgkin's disease. Blood 87:2905, 1996
13. Chan JCK, Ng CS, Hui PK, Leung TW, Lo ESF, Lau WH, McGuire LJ: Anaplastic large-cell Ki-1 lymphoma: Delineation of two morphological types. Histopathology 15:11, 1989
14. Tashiro K, Kikuchi M, Takeshita M, Yoshida T, Oshima K: Clinicopathological study of Ki-1-positive lymphomas. Pathol Res Pract 185:461, 1989
15. Chott A, Kaserer K, Augustin I, Vesely M, Heintz R, Oehlinger W, Hanak H, Radszkiewcz T: Ki-1 positive large-cell lymphoma. A clinico pathologic study of 41 cases. Am J Surg Pathol 14:439, 1990
16. Offit K, Ladanyi M, Gangi MD, Ebrahim SAD, Filippa D, Chaganti RSK: Ki-1 expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma. Leukemia 4:625, 1990
17. Greer JP, Kinney MC, Collins RD, Salhany KE, Wolff SN, Hainsworth JD, Flexner JM, Stein RS: Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 9:539, 1991
18. Nakamura S, Takagi N, Kojima M, Motoori T, Kitoh K, Osada H, Suzuki H, Ogura M, Kurita S, Oyama A, Ueda R, Takahashi T, Suchi T: Clinicopathologic study of anaplastic large cell lymphoma (Ki-1 positive large cell lymphoma) among the Japanese. Cancer 68:118, 1991
19. Penny RJ, Blaustein JC, Longtine JA, Pinkus GS: Ki-1 positive large-cell lymphoma, a heterogeneous group of neoplasms. Cancer 68:362, 1991
20. De Bruin PC, Beljaards RC, Van Heerde P, Van Der Walk P, Noorduyns LA, Van Krieken JHJM, Kluin-Nelemans JC, Willemze R, Meijer CJLM: Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology 23:127, 1993
21. Schulmun LN, Frisard B, Antin JH, Wheeler C, Pinkus G, Magauran N, Mauch P, Nobles E, Mashal R, Canellos G, Tung N, Kadin M: Primary Ki-1 anaplastic large-cell lymphoma in adults: Clinical characteristics and therapeutic outcome. J Clin Oncol 11:937, 1993
22. Pileri S, Bocchia M, Buroni CD, Martelli M, Falini B, Sabattini E, Ghertinzoni F, Amadori S, Poggi S, Mazza P, Burgio V, Zinzani PL, Melilli G, Benni M, Saragoni L, Martelle MF, Stein H, Manadelli F, Tura S: Anaplastic large cell lymphoma (CD30+/Ki-1+): Results of a prospective Clinicopathological study of 69 cases. Br J Haematol 86:513, 1994
23. Romaguera JE, Manning JT Jr, Tornos CS, Rodriguez J, Brooks TE, Pugh WB, Ordonez NG, Goodacre AM, Cabanillas F: Long-term prognostic importance of primary Ki1 (CD30) antigen expression and anaplastic morphology in adults patients with diffuse large cell lymphoma. Ann Oncol 5:317, 1994
24. Tirelli U, Vaccher E, Zagonel V, Talamini R, Bernardi D, Tavia M, Gloghini A, Merola MC, Monfardini S, Carbone A: CD30 (Ki-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: The first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related lymphomas. J Clin Oncol 13:373, 1995
25. Fanin R, Silvestri F, Geromin A, Cerno M, Infanti L, Zaja F, Barillari G, Savignano C, Rinaldi C, Damiani D, Buffoli A, Biffoni F, Baccarani M: Primary systemic CD30 (Ki-1)-positive anaplastic large cell lymphoma of the adult: Sequential intensive treatment with F-MACHOP regimen (± radiotherapy) and autologous bone marrow transplantation. Blood 87:1243, 1996
26. Zinzani PL, Bendandi M, Martelli M, Falini B, Sabattini E, Amadori S, Gherlinzoni F, Martelli MF, Mandelli F, Tura S, Pileri SA: Anaplastic large-cell lymphoma: Clinical and prognostic evaluation of 90 adult patients. J Clin Oncol 14:955, 1996
27. Clavio M, Rossi E, Truini M, Carrara P, Ravetti JL, Spriano M, Vimercati AR, Santini G, Canepa L, Pierri I, Celesti L, Miglino M, Castellaneta A, Damasio E, Gobbi M: Anaplastic large cell lymphoma: A clinicopathologic study of 53 cases. Leuk Lymphoma 22:319, 1996
28. Non-Hodgkin's lymphoma classification project: National Cancer Institute study of classification of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112, 1982
29. Stansfeld AG, Diebold J, Kapanci Y, Kelényi G, Lennert K, Mioduszewska O, Noel H, Rilke F, Sunstrom C, Van Unnik JAM, Wright DH: Updated Kiel classification for lymphomas. Lancet 1:292, 1988
30. Stein H, Herbst H, Anagnostopoulos I, Niedobitek G, Dallenbach F, Kratzsch HC: The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large cell lymphoma. Ann Oncol 2:33, 1991
31. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M: Report of the committee on Hodgkin's disease staging classification. Cancer Res 31:1860, 1991
32. The international non-Hodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987, 1993
33. Coiffier B, Gisselbrecht C, Herbrecht R, Tilly H, Bosly A, Brousse N: LNH-84 regimen: A multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. J Clin Oncol 7:1018, 1989
34. Shipp MA, Yeap BY, Harrington DP, Klatt MM, Pinkus GS, Jochelson MS, Rosenthal DS, Skarin AT, Canellos GP: The m-BACOD combination chemotherapy regimen in large-cell lymphoma: Analysis of the completed trial and comparison with the M-BACOD regimen. J Clin Oncol 8:84, 1990
35. Haioun C, Lepage E, Gisselbrecht C, Coiffier B, Bosly A, Tilly H, Morel P, Nouvel C, Herbrecht R, d'Agay MF, Gaulard P, Reyes F: Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: A study of 464 patients. J Clin Oncol 12:2543, 1994
36. Bosly A, Lepage E, Coiffier B, Dupriez B, Herbrecht R, Fillet G, Diviné M, Nouvel C, Tilly H, Bordessoule D, Gaulard P, Gisselbrecht C: In elderly patients with non-Hodgkin's lymphoma, alternance of chemotherapy is not superior to ACVBP + consolidation: A prospective randomized study on 884 patients LNH87 protocol group 3. Ann Oncol 7:60 1996 (suppl 3, abstr)
37. Bastion Y, Blay JY, Diviné M, Brice P, Bordessoule D, Sebban C, Blanc M, Tilly H, Lederlin P, Deconinck E, Salles B, Brière J. Coiffier B: Elderly patients with aggressive lymphoma survive longer if treated with a curative intent. A GELA study on 453 patients older than 69 years. J Clin Oncol (in press)
38. Kaplan EL, Meier P: Nonparametric estimation for incomplete observations. J Am Stat Assoc 53:457, 1958
39. Cox DR: Regression models and life-tables: J R Stat Soc [B] 34:187, 1972
40. Kinney MC, Collins RD, Greer JP, Whitlock JA, Sioutos N, Kadin ME: A small-cell variant of primary Ki-1 (CD30+) T-cell lymphoma. Am J Surg Pathol 17:859, 1993
41. + anaplastic large-cell lymphoma. J Clin Oncol 13:1355, 1995
42. Gause A, Pohl C, Tschiersch A, Da Costa L, Jung W, Diehl V, Hasenclever D, Pfreundschuh M: Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease. Blood 77:1983, 1991
43. Nadali G, Vinante F, Ambrosetti A, Todeschini G, Veneri D, Zanotti R, Meneghini V, Ricetti MM, Benedetti F, Vassanelli A, Perona G, Chilosi M, Menestrina F, Fiacchini M, Stein H, Pizzolo G: Serum levels of soluble CD30 are elevated in the majority of untreated patients with Hodgkin's disease and correlate with clinical features and prognosis. J Clin Oncol 12:793, 1994
44. Wood GS, Hardman DL, Boni R, Dummer R, Kim YH, Smoller BR, Takeshita M, Kikuchi M, Burg G: Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease. Blood 88:1765, 1996
45. Paulli M, Berti E, Rosso R, Boveri E, Kindl S, Klersy C, Azzarino M, Borroni G, Menestrina F, Santucci M, Gambini C, Vassalo G, Magrini U, Sterry W, Burg G, Geerts ML, Meijer CJLM, Willemze R, Feller AC, Müller-Hermelink HK, Kadin ME: CD30/Ki-1 positive lymphoproliferative disorders of the skin. Clinicopathologic correlation and statistical analysis of 86 cases: A multicentric study from the European Organization for Research and Treatment of Cancer cutaneous lymphoma project group. J Clin Oncol 13:1343, 1995
46. Reiter A, Schrappe M, Tiemann M, Parwaresch, Zimmermann, Yakisan E, Dopfer R, Bucksy P, Mann G, Gadner H, Riehm H: Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: A prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies. J Clin Oncol 12:899, 1994
47. Fraga M, Brousset P, Schlaifer D, Payen C, Robert A, Rubie H, Huguet-Rigal F, Delsol G: Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance. Am J Clin Pathol 103:82, 1995
48. Kadin ME: Ki1/CD30+ (Anaplastic) large-cell lymphoma: Maturation of a clinicopathologic entity with prospects of effective therapy. J Clin Oncol 12:884, 1994
49. Shiota M, Fujimoto J, Takenaga M, Satoh H, Ichinohasama R, Abe M, Nakano M, Yamamoto T, Mori S: Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 84:3648, 1994
50. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Groupe Classification of non-Hodgkin's lymphoma. Blood 89:3909, 1997
51. Coiffier B, Brousse N, Peuchmaur M, Berger F, Gisselbrecht C, Bryon PA, Diebold J: Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: A prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. Ann Oncol 1:45, 1990